Financial Instruments - Additional Information (Detail) - USD ($) |
1 Months Ended | |
---|---|---|
Sep. 30, 2022 |
Nov. 16, 2021 |
|
Schedule Of Available For Sale Securities [Line Items] | ||
Sale of stock price per share | $ 27.74 | |
Other Assets | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Strategic investment | $ 2,750,000 | |
Stock Consideration [Member] | PandoLogic Merger Agreement [Member] | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Sale of stock price per share | $ 20.53 | |
Minimum [Member] | ||
Schedule Of Available For Sale Securities [Line Items] | ||
Contingent earnout | $ 10,825,000 |
X | ||||||||||
- Definition Cost of the investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Business combination fair value of earnout within contingent consideration. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|